Chronic Care Pharmacy-at-Home
Home-based pharmacy services for patients with multiple chronic conditions
Service · HybridCompany source
Company profile
About Tabula Rasa Healthcare
AnewHealth was established in 2023 through the combination of ExactCare Pharmacy and Tabula Rasa Healthcare, creating a national medication management and pharmacy care provider serving more than 150,000 people with complex, chronic needs across all 50 states and Washington, D.C. The company specializes in delivering integrated clinical pharmacy and technology solutions that optimize care and outcomes for people with the most complex, chronic care needs and the healthcare organizations that care for them. AnewHealth's approach combines decades of pharmacy expertise with proprietary MedWise® technology to personalize medication optimization through comprehensive multi-drug analysis. This science-based methodology identifies health risks, provides data-driven insights to clinicians at the point of care, and enables proactive mitigation of adverse drug events and negative health outcomes. The company's solutions make it easier for patients to take medications as prescribed while helping healthcare organizations achieve better clinical and cost outcomes. The company serves multiple customer segments including risk-bearing providers, PACE organizations, health plans (Medicare, Medicaid, Dual-Eligible, SNP, and MLTSS), home health providers, and patients with multiple chronic conditions. AnewHealth also operates Pharmastar, a full-service pharmacy benefit manager with over 20 years of experience and a national network of 64,000+ pharmacies. The company has demonstrated proven results including statistically significant increases in medication adherence, 40% fewer readmissions for home health patients, 10% reduction in annual hospital admissions for PACE participants, and cost savings ranging from $4,000 to $5,000+ per member annually.
Company description Tabula Rasa Healthcare official website
Primary marketPharmacy & Medication Management
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Tabula Rasa Healthcare?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- complex chronic care needs
- multiple chronic conditions
Who it serves
- Case Management
- Health Plans
- Home Health
- IDD and Residential Care
- Kidney Care Providers
- PACE Organizations
- Primary Care
- Risk-Bearing Providers
- Specialty Providers
Deployment & integration
Cloud Saas · Hybrid · Other deployment with recorded integration context.
Geographic context
MarketsAll 50 states · United States · Washington D.C.
Company sourceOfficial website
Company milestones
Platform expansion
Established in 2023 through combination of ExactCare Pharmacy and Tabula Rasa Healthcare. Serves more than 150,000 people nationwide.
Partnerships
Recorded partners
- 64,000+ pharmacy network
- PACE organizations nationwide
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Consulting for PACE
Strategic consulting services for PACE organizations
Service · OtherCompany source
End-to-End Pharmacy Care Management
Comprehensive medication management for complex chronic care patients
Service · HybridCompany source
MedWise
Proprietary technology for personalized medication optimization and multi-drug analysis
Platform · Cloud SaaSCompany source
Pharmacy for IDD Facilities
Pharmacy services for intellectual and developmental disabilities residential care
Service · HybridCompany source
Pharmacy for PACE
Specialized pharmacy services for PACE organizations nationwide
Service · HybridCompany source
Pharmastar PBM
Full-service pharmacy benefit management with 20+ years of experience
Platform · Cloud SaaSCompany source
Risk Adjustment Solutions
Risk adjustment and quality measure optimization for value-based care
Service · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Chronic Pain Management in a CYP2D6 Poor Metabolizer: A Case Report for Oxycodone.The Senior care pharmacist · Apr 1, 2024
Utilizing Pharmacogenomics Results to Guide Antidepressant Selection: A Case Report.The Senior care pharmacist · Apr 1, 2024
Utilizing Pharmacogenomics Results to Improve Statin-Associated Muscle Symptoms.The Senior care pharmacist · Apr 1, 2024
The Blood-Brain Barrier in Health and Disease.International journal of molecular sciences · May 25, 2023
Reply to: Commentary on: Pharmacist-driven interventions to de-escalate urinary antimuscarinics in the Programs of All-Inclusive Care for the Elderly.Journal of the American Geriatrics Society · Mar 1, 2023
Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report.The American journal of case reports · Feb 21, 2023
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Statistically significant increases in medication adherence
Risk-bearing, primary care, specialty, and home health providers
40% fewer readmissions
Home health patients
20 percentile point increase in OASIS M2020
Home health quality measures
+83 NPS
Primary care patients
10% reduction in annual hospital admissions
PACE participants
$5,000+ cost savings per participant annually
PACE organizations
5-Star performance for adherence based on PDC
Health plans
Up to $4,000 annual savings per member
Health plans
+75 NPS
Health plan members
+78 NPS for 2024
Overall patient satisfaction survey
Health Plans
Achieving 5-Star performance and reducing healthcare costs for Medicare and Medicaid plans
5-Star performance for adherence based on PDC, annual savings up to $4,000 per member, +75 NPS
Home Health Provider
Reducing hospital readmissions and improving medication adherence for home health patients
40% fewer readmissions for home health patients
PACE Organizations
Reducing hospital admissions and costs for PACE participants
10% reduction in annual hospital admissions and cost savings over $5,000 per participant annually
Primary Care Provider
Enhancing patient satisfaction and medication adherence in primary care
+83 NPS for primary care patients
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Tabula Rasa Healthcare
Recent articles published on Tabula Rasa Healthcare's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Pharmacy & Medication Management
Companies using AI for medication optimization, pharmacy automation, drug pricing and access, medication adherence, polypharmacy management, or pharmacy workflow optimization. Includes platforms that help patients access affordable medications, tools that reduce medication errors, and AI systems that optimize drug regimens for complex patients.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.